Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The critical role of medication adherence in the success of boceprevir and telaprevir in clinical practice.

× No keyword cloud information.

8 in total

Review 1. Protease inhibitors for hepatitis C: economic implications.

Authors: Stuart J Turner; Jack Brown; Joseph A Paladino
Journal: Pharmacoeconomics Date: 2013-09 Impact factor: 4.981

2. Impact of hepatitis C treatment initiation on adherence to concomitant medications.

Authors: Maria Pizzirusso; Jenny Lin; Cory Head; Sue M Marcus; Samia Ahmed; Norbert Bräu; Jeffrey J Weiss
Journal: J Assoc Nurses AIDS Care Date: 2013-09-24 Impact factor: 1.354

3. Efficacy and safety of danoprevir-ritonavir plus peginterferon alfa-2a-ribavirin in hepatitis C virus genotype 1 prior null responders.

Authors: Edward J Gane; Régine Rouzier; Alicja Wiercinska-Drapalo; Dominique G Larrey; Peter N Morcos; Barbara J Brennan; Sophie Le Pogam; Isabel Nájera; Rosemary Petric; Jonathan Q Tran; Rohit Kulkarni; Ying Zhang; Patrick Smith; Ellen S Yetzer; Nancy S Shulman
Journal: Antimicrob Agents Chemother Date: 2013-12-02 Impact factor: 5.191

4. Adherence during antiviral treatment regimens for chronic hepatitis C: a qualitative study of patient-reported facilitators and barriers.

Authors: Donna M Evon; Carol E Golin; Jason E Bonner; Catherine Grodensky; Jennifer Velloza
Journal: J Clin Gastroenterol Date: 2015 May-Jun Impact factor: 3.062

8. A Randomized Controlled Trial to Assess the Impact of Clinical Pharmacy Interventions on Treatment Outcomes, Health Related Quality of Life and Medication Adherence Among Hepatitis C Patients.

Authors: Salamat Ali; Mashhood Ali; Vibhu Paudyal; Faisal Rasheed; Shahan Ullah; Sayeed Haque; Tofeeq Ur-Rehman
Journal: Patient Prefer Adherence Date: 2019-12-13 Impact factor: 2.711

8 in total

The critical role of medication adherence in the success of boceprevir and telaprevir in clinical practice.

Review 1. Protease inhibitors for hepatitis C: economic implications.

2. Impact of hepatitis C treatment initiation on adherence to concomitant medications.

3. Efficacy and safety of danoprevir-ritonavir plus peginterferon alfa-2a-ribavirin in hepatitis C virus genotype 1 prior null responders.

4. Adherence during antiviral treatment regimens for chronic hepatitis C: a qualitative study of patient-reported facilitators and barriers.

Review 5. Patient adherence issues in the treatment of hepatitis C.

6. "Fighting an uphill battle": experience with the HCV triple therapy: a qualitative thematic analysis.

7. The role of Aboriginal community attachment in promoting lifestyle changes after hepatitis C diagnosis.

8. A Randomized Controlled Trial to Assess the Impact of Clinical Pharmacy Interventions on Treatment Outcomes, Health Related Quality of Life and Medication Adherence Among Hepatitis C Patients.